Michael Dyson

Michael Dyson

Company: Ichnos Science

Job title: Vice President, Antibody Discovery & Engineering


Navigating the Complexity & Developability Challenges in Multispecific Antibody Therapeutics 4:45 pm

Understanding the transition from monovalent to multivalent formats in antibody development Importance of comprehensive developability assessment in choosing clinical candidates Strategies for successful characterization and production of multispecific antibody therapeuticsRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.